» Articles » PMID: 12915619

Endocrine Treatment of Transsexual People: a Review of Treatment Regimens, Outcomes, and Adverse Effects

Overview
Specialty Endocrinology
Date 2003 Aug 14
PMID 12915619
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Cross-sex hormone treatment is an important component in medical treatment of transsexual people. Endocrinologists are often faced with designing treatment recommendations. Although guidelines from organizations, such as the Harry Benjamin International Gender Dysphoria Association, have been helpful, management remains complex and experience guided. We discuss the range of treatment used by transsexual people, the rationale behind these, and the expectation from such treatment. Recommendations from seven clinical research centers treating transsexual people are discussed. In addition, self-reported hormonal regimens from 25 male-to-female transsexual people and five female-to-male transsexual people are reported. Finally, the potential adverse effects of cross-sex hormone treatment of transsexual people are reviewed. In light of the complexity of managing treatment goals and adverse effects, the active involvement of a medical doctor experienced in cross-sex hormonal therapy is vital to ensure the safety of transsexual people.

Citing Articles

Shortcomings of transgender identity concealment research: a scoping review of associations with mental health.

Osmetti L, Allen K, Kozlowski D Int J Transgend Health. 2025; 26(1):25-49.

PMID: 39981286 PMC: 11837921. DOI: 10.1080/26895269.2024.2367653.


Gender Incongruence in Danish Youth (GenDa): A Protocol for a Retrospective Cohort Study of Danish Children and Adolescents Referred to a National Gender Identity Service.

Ravnborg N, Aslam M, Norup P, Tingsgard J, Pagsberg A, Haahr M J Clin Med. 2024; 13(22).

PMID: 39597802 PMC: 11595080. DOI: 10.3390/jcm13226658.


Impact of Gender-Affirming Hormonal Therapy on Cardiovascular Risk Factors in Transgender Health: An Updated Meta-Analysis.

Rahman S, Manasrah N, Kumar N, Hamza M, Sharma A, Patel N JACC Adv. 2024; 3(10):101265.

PMID: 39309657 PMC: 11414688. DOI: 10.1016/j.jacadv.2024.101265.


Healthcare access and barriers to utilization among transgender and gender diverse people in Africa: a systematic review.

Jessani A, Berry-Moreau T, Parmar R, Athanasakos A, Prodger J, Mujugira A BMC Glob Public Health. 2024; 2(1):44.

PMID: 38948028 PMC: 11208260. DOI: 10.1186/s44263-024-00073-2.


Gender-affirming hormone treatment: friend or foe? Long-term follow-up of 755 transgender people.

Santi D, Spaggiari G, Marinelli L, Cacciani M, Scipio S, Bichiri A J Endocrinol Invest. 2023; 47(5):1091-1100.

PMID: 37889433 DOI: 10.1007/s40618-023-02220-2.